Navigation Links
LamdaGen Corporation Announces Japan Patent Issuance for Enzymatic Diagnostic Assays on Plasmonic Nano-Sensors
Date:4/4/2013

MENLO PARK, Calif., April 4, 2013 /PRNewswire/ -- LamdaGen Corporation, a nano-technology platform company that provides plasmonic sensors and systems for diagnostics and life sciences, announced the Japanese Patent Office issuance of patent number 5203390, "Enzymatic Assays for LSPR", which enables highly sensitive and quantitative diagnostics.

"The issuance of this patent underscores LamdaGen's unique ability to harness the significant potential of modern plasmonics in greatly enhancing the detection sensitivity and speed of current immuno-diagnostics," commented Randy Storer , CEO and Co-Founder of LamdaGen Corporation. "We are working with a number of companies to integrate our powerful technology into their existing diagnostic systems and devices or advanced IVD systems they have under development."

The patent claims broadly cover nano-plasmonic surfaces and particles used in various ways as solid supports for high-speed plasmonic ELISA assays. The methods can facilitate detection limits into the femtomolar range, nearly four orders of magnitude lower than that of conventional ELISA assays.

About LamdaGen Corporation

LamdaGen is a nano-technology platform company providing plasmonic sensors and analytical systems for diagnostic and life science markets. The company's Localized Surface Plasmon Resonance (LSPR) sensors and systems enable real-time detection of biomolecular interactions, as well as enzymatic and chemical reactions. LamdaGen is a privately held company headquartered in Menlo Park, California and is the first to offer commercial LSPR products. For more information, visit www.lamdagen.com or email info@lamdagen.com

Media Contact:
Alice F. Huang
650-571-5816
ahuang@lamdagen.com


'/>"/>
SOURCE LamdaGen Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
2. Kensey Nash Corporation Announces Achievement of $6 Million Milestone From Spectranetics Corporation
3. China Cord Blood Corporation Announces Results of 2011 Annual General Meeting
4. Neogen Corporation Announces 2nd Quarter Results Conference Call
5. Luminex Corporation to Present at JP Morgan Healthcare Conference
6. Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
7. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
8. JBT Corporation and Swisslog Enter Into Partnership for Automated Guided Vehicles
9. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012
10. Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results
11. Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2017)... (PRWEB) , ... March 20, ... ... substances that interfere with the ability of endogenous hormones to regulate homeostasis ... ligand binding activity (antagonists), EDCs produce adverse reproductive, neurological, proliferative, and immunological ...
(Date:3/20/2017)... ... March 20, 2017 , ... Existing methods using LC-MS/MS suffer ... to reduce the impact on instrumentation. ICP-MS is a robust and specific analytical ... , This presentation will discuss the pros and cons of using LC-ICP-MS for ...
(Date:3/20/2017)... ... March 20, 2017 , ... Park Systems, a leader in Atomic Force Microscopy ... 24, 2017 from 5-7pm at their Santa Clara facility that will include craft beer ... Researcher, Dr. Tae-Gon Kim. , Dr. Tae-Gon Kim, Senior researcher at imec Belgium and ...
(Date:3/20/2017)... , March 20, 2017  Attorney Advertising -- Bronstein, Gewirtz ... purchasers of the BioAmber Inc. ("BioAmber" or the "Company") (NYSE: ... information and assist the investigation by visiting the firm,s site: ... BioAmber and certain of its officers and/or directors have violated ... 1934. ...
Breaking Biology Technology:
(Date:3/16/2017)... , March 16, 2017 CeBIT 2017 - Against identity fraud with ... Reading ... Used combined in one project, multi-biometric solutions provide a crucial ... Used combined in ... ...
(Date:3/7/2017)...   HireVue , the leading provider of video ... best talent, faster, today announced the additions of ... Diana Kucer as Chief Marketing Officer (CMO). ... poised to drive continued growth in the company,s new ... record bookings in 2017. "Companies worldwide turn ...
(Date:3/2/2017)... Australian stem cell and regenerative medicine company, ... an agreement with the Monash Lung Biology Network, a ... and Department of Pharmacology at Monash University, ... to support the use of Cymerus™ mesenchymal stem cells ... Asthma is a chronic, long term lung condition recognised ...
Breaking Biology News(10 mins):